The Food and Drug Administration today reported 55 injuries and one death involving an infusion pump and vital signs monitoring system. Becton Dickinson CareFusion 303 Inc. recalled the Alaris Infusion Pump System and Modules in February due to software and other errors that can delay, speed or interrupt the infusion of medications and other fluids to patients. According to FDA, consumers should follow the manufacturer’s recommended actions to help mitigate the potential risk of errors until the software issues have been remediated. Health care providers may report associated adverse reactions or quality problems to FDA’s MedWatch reporting program.

Related News Articles

Blog
I recall vividly my five years as a member of the AHA Board of Trustees and ultimately becoming the Chairman of the Board in 2011. Many of the experiences were…
Blog
When the COVID-19 pandemic hit, ensuring one’s physical health became the priority. As the toll of social distancing and prolonged stay-in-place orders have…
Headline
The AHA Friday outlined a number of actions Congress could take to help the nation prepare for the next pandemic, noting that the current pandemic also remains…
Headline
A National Quality Forum task force today released a report identifying opportunities to advance safe, appropriate, person-centered care over the next decade…
Headline
The Department of Health and Human Services today said its Office of Minority Health will partner with the Morehouse School of Medicine to deliver education…
Headline
Hospitalization rates for COVID-19 were nearly four times higher for black, and two times higher for Hispanic, Medicare beneficiaries than for white Medicare…